Publication Details
Overview
 
 
Luuk H. Boulogne, Julian Lorenz, Daniel Kienzle, Robin Schon, Katja Ludwig, Rainer Lienhart, Simon Jegou, Guang Li, Cong Chen, Qi Wang, Derik Shi, Mayug Maniparambil, Dominik Muller, Silvan Mertes, Niklas Schroter, Fabio Hellmann, Miriam Elia, Ine Dirks, Matías Bossa, Matías Bossa, Abel Díaz Berenguer, Tanmoy Mukherjee, ne_list"Tanmoy Mukherjee, Jef Vandemeulebroucke, Hichem Sahli, Nikos Deligiannis, Panagiotis Gonidakis, Ngoc Dung Huynh, Imran Razzak, Reda Bouadjenek, Mario Verdicchio, Pasquale Borrelli, Marco Aiello, James A. Meakin, Alexander Lemm, Christoph Russ, Razvan Ionasec, Nikos Paragios, Bram van Ginneken, Marie-Pierre Revel Dubois
 

Medical Image Analysis

Contribution To Journal

Abstract 

Challenges drive the state-of-the-art of automated medical image analysis. The quantity of public training data that they provide can limit the performance of their solutions. Public access to the training methodology for these solutions remains absent. This study implements the Type Three (T3) challenge format, which allows for training solutions on private data and guarantees reusable training methodologies. With T3, challenge organizers train a codebase provided by the participants on sequestered training data. T3 was implemented in the STOIC2021 challenge, with the goal of predicting from a computed tomography (CT) scan whether subjects had a severe COVID-19 infection, defined as intubation or death within one month. STOIC2021 consisted of a Qualification phase, where participants developed challenge solutions using 2000 publicly available CT scans, and a Final phase, where participants submitted their training methodologies with which solutions were trained on CT scans of 9724 subjects. The organizers successfully trained six of the eight Final phase submissions. The submitted codebases for training and running inference were released publicly. The winning solution obtained an area under the receiver operating characteristic curve for discerning between severe and non-severe COVID-19 of 0.815. The Final phase solutions of all finalists improved upon their Qualification phase solutions.

Reference 
 
 
DOI DOI scopus VUB